AI Article Synopsis
- Novel antiemetic drugs target neurokinin-1 or serotonin-3 receptors to prevent vomiting.
- Studies on how substance P and serotonin work together in the brain are revealing new potential uses for neurokinin-1 antagonists.
- These insights could lead to additional treatments for conditions like depression and stress beyond just anti-nausea effects.
Article Abstract
Novel antiemetic drugs block either neurokinin-1 receptors or serotonin-3 receptors. Research into the neuropharmacology of vomiting is providing insight into the ways substance P and serotonin interact within the central nervous system that could lead to additional applications of neurokinin-1 antagonists for the treatment of depression and stress.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4088/jcp.v64n0601 | DOI Listing |
Publication Analysis
Top Keywords
novel antiemetic
8
antiemetic drugs
8
downs novel
4
drugs illustration
4
illustration novel
4
drugs block
4
block neurokinin-1
4
neurokinin-1 receptors
4
receptors serotonin-3
4
serotonin-3 receptors
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!